Source: Milwaukee Journal Sentinel
Posted: Jan. 9, 2006
From the Jan. 10, 2006 editions of the Milwaukee Journal Sentinel
By KAWANZA NEWSON
knewson@journalsentinel.com
Scientists have used embryonic stem cells to correct the mutation that causes sickle cell disease in mice, a preliminary finding that may lead to treatment options for people with the painful and debilitating disease. Although it is unknown if the technique will ultimately work in humans, the research suggests the technique could allow people born with this genetic defect to live with few or no complications from their illness.
No comments:
Post a Comment